Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
出版年份 2019 全文链接
标题
Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
作者
关键词
-
出版物
DRUGS & AGING
Volume 36, Issue 6, Pages 511-530
出版商
Springer Science and Business Media LLC
发表日期
2019-04-02
DOI
10.1007/s40266-019-00654-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study)
- (2019) Olaf Krause et al. BMC Geriatrics
- Orthostatic hypotension in Parkinson disease: Impact on health care utilization
- (2018) Aristide Merola et al. PARKINSONISM & RELATED DISORDERS
- The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
- (2018) Manon Auffret et al. Drugs in research & development
- Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson’s Disease Patients
- (2018) Martin Klietz et al. Frontiers in Neurology
- Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson’s Disease: A Cross-Sectional Study
- (2018) Marina Peball et al. GERONTOLOGY
- Prevalent cerebrovascular and cardiovascular disease in people with Parkinson’s disease: a meta-analysis
- (2018) Chien Tai Hong et al. Clinical Epidemiology
- Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study
- (2018) Monika Balzer-Geldsetzer et al. BMC Neurology
- Gastrointestinal Dysfunction in Parkinson’s Disease
- (2018) Ronald F. Pfeiffer Current Treatment Options in Neurology
- Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson’s disease
- (2018) Fabrizio Stocchi et al. Expert Opinion on Drug Metabolism & Toxicology
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2018) J.A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Comparative analysis of three drug–drug interaction screening systems against probable clinically relevant drug–drug interactions: a prospective cohort study
- (2017) Neža Muhič et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Opicapone for the treatment of Parkinson’s disease
- (2017) Filipe B Rodrigues et al. EXPERT OPINION ON PHARMACOTHERAPY
- Delirium in Older Persons
- (2017) Esther S. Oh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
- (2017) Emanuele Cereda et al. JOURNAL OF NEUROLOGY
- Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings
- (2017) Jingjing Yu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Pharmakotherapie des Morbus Parkinson
- (2017) S. Müller-Rebstein et al. NERVENARZT
- Polypharmacy and Medication Management in Older Adults
- (2017) Jennifer Kim et al. NURSING CLINICS OF NORTH AMERICA
- Disturbances of thirst and fluid balance associated with aging
- (2017) Denovan P. Begg PHYSIOLOGY & BEHAVIOR
- Managing Polypharmacy in the 15-Minute Office Visit
- (2017) Demetra Antimisiaris et al. PRIMARY CARE
- Morbus Parkinson im Alter
- (2017) Rüdiger Lange et al. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
- Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
- (2017) Jose A. Santiago et al. Frontiers in Aging Neuroscience
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
- (2017) Rajesh Pahwa et al. JAMA Neurology
- Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy
- (2017) Sebastian Loens et al. Brain and Behavior
- Factors associated with motor complications in Parkinson's disease
- (2017) Liis Kadastik-Eerme et al. Brain and Behavior
- The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly
- (2016) Farhad Pazan et al. DRUGS & AGING
- Impulse control disorder related behaviours during long-term rotigotine treatment: apost hocanalysis
- (2016) A. Antonini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies
- (2016) Robert A. Hauser et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Predicting drug-induced QT prolongation and torsades de pointes
- (2016) Dan M. Roden JOURNAL OF PHYSIOLOGY-LONDON
- Predictive Validity of the Beers and Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States
- (2016) Joshua D. Brown et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Polyneuropathy in levodopa-treated Parkinson's patients
- (2016) Karol Szadejko et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons
- (2016) Martin Klietz et al. NEUROSCIENCE
- Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients
- (2016) A. Heranval et al. REVUE NEUROLOGIQUE
- Liver function declines with increased age
- (2016) Kasia P. Cieslak et al. HPB
- Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
- (2016) Fabrizio Stocchi et al. Drug Design Development and Therapy
- Too much medicine in older people? Deprescribing through shared decision making
- (2016) Jesse Jansen et al. BMJ-British Medical Journal
- Too much medicine in older people? Deprescribing through shared decision making
- (2016) Jesse Jansen et al. BMJ-British Medical Journal
- Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease
- (2016) Daniel Weintraub et al. JAMA Neurology
- Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease
- (2016) James A. G. Crispo et al. PLoS One
- Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
- (2015) Thomas Müller DRUGS
- The epidemiology and risk factors of chronic polyneuropathy
- (2015) Rens Hanewinckel et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Renal tubular secretion of pramipexole
- (2015) Jana Knop et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
- (2015) Mikko Kuoppamäki et al. JOURNAL OF NEURAL TRANSMISSION
- Global Prevalence of Physical Frailty by Fried's Criteria in Community-Dwelling Elderly With National Population-Based Surveys
- (2015) Jaekyung Choi et al. Journal of the American Medical Directors Association
- Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease
- (2015) Mona Sadeghian et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Striatal tyrosine hydroxylase-positive neurons are associated with l-DOPA-induced dyskinesia in hemiparkinsonian mice
- (2015) U. Keber et al. NEUROSCIENCE
- Role of homocysteine in the development of cardiovascular disease
- (2015) Paul Ganguly et al. Nutrition Journal
- Risk and adverse outcomes of fractures in patients with Parkinson’s disease: two nationwide studies
- (2015) Y.-F. Huang et al. OSTEOPOROSIS INTERNATIONAL
- Increased risk of Parkinson's disease in cataract patients: A population-based cohort study
- (2015) Shih-Wei Lai et al. PARKINSONISM & RELATED DISORDERS
- Severity of orthostatic hypotension in the course of Parkinson's disease: No correlation with the duration of the disease
- (2015) Wolfgang H. Jost et al. PARKINSONISM & RELATED DISORDERS
- Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type-B inhibitor: A Cross-Sectional, Cohort Study
- (2015) Khashayar Dashtipour et al. PHARMACOTHERAPY
- Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study
- (2015) Frank Moriarty et al. BMJ Open
- Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review
- (2015) Janine A Cooper et al. BMJ Open
- Reducing Inappropriate Polypharmacy
- (2015) Ian A. Scott et al. JAMA Internal Medicine
- Gyógyszerkölcsönhatások kiszűrésére szolgáló adatbázisok értékelése: ellentmondások és egyezőségek
- (2015) Anna Somogyi-Végh et al. ORVOSI HETILAP
- Hipocalcemia grave y deterioro cognitivo en paciente con hipoparatiroidismo y esclerosis sistémica. A propósito de un caso
- (2015) Óscar Moreno et al. Endocrinologia y Nutricion
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
- (2014) Denis O'Mahony et al. AGE AND AGEING
- Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence fromIn VivoCanine Models
- (2014) Yudai Watanabe et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusionvs. oral tablets
- (2014) Ahmed A. Othman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease
- (2014) Tomoaki Kumagai et al. CLINICAL NEUROPHARMACOLOGY
- Treatment of advanced Parkinsonʼs disease
- (2014) Juan C. Giugni et al. CURRENT OPINION IN NEUROLOGY
- Pharmacologic Options in the Management of Upper Gastrointestinal Bleeding: Focus on the Elderly
- (2014) Moe Htet Kyaw et al. DRUGS & AGING
- Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson’s disease
- (2014) Michele A Faulkner Expert Opinion On Drug Safety
- Optimizing polypharmacy among elderly hospital patients with chronic diseases—study protocol of the cluster randomized controlled POLITE-RCT trial
- (2014) Christin Löffler et al. Implementation Science
- The Prevalence of Diabetic Cardiomyopathy: A Population-Based Study in Olmsted County, Minnesota
- (2014) Sanjay Dandamudi et al. JOURNAL OF CARDIAC FAILURE
- Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson’s disease
- (2014) Chang-Qing Zhou et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease
- (2014) V. Kotagal et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease
- (2014) Robert A. Hauser et al. MOVEMENT DISORDERS
- Multimorbidität: Konzept, Epidemiologie, Versorgung
- (2014) R. Dodel NERVENARZT
- Cardiovascular effects of levodopa in Parkinson's disease
- (2014) Cornelia Noack et al. PARKINSONISM & RELATED DISORDERS
- Reasons for hospitalization in Parkinson's disease: A case-control study
- (2014) Massimiliano Braga et al. PARKINSONISM & RELATED DISORDERS
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
- (2014) Michel Panisset et al. PHARMACOTHERAPY
- Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
- (2014) Nevena Divac et al. Biomed Research International
- Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older
- (2013) Elke S. Schaeffner et al. ANNALS OF INTERNAL MEDICINE
- Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects
- (2013) José Francisco Rocha et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly
- (2013) Alexandra M. Kuhn-Thiel et al. DRUGS & AGING
- Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine
- (2013) Willi Cawello et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- The practical management of cognitive impairment and psychosis in the older Parkinson’s disease patient
- (2013) John V. Hindle JOURNAL OF NEURAL TRANSMISSION
- Diabetes is associated with postural instability and gait difficulty in Parkinson disease
- (2013) Vikas Kotagal et al. PARKINSONISM & RELATED DISORDERS
- Parkinson's disease and osteoporosis
- (2012) F. van den Bos et al. AGE AND AGEING
- Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
- (2012) Yoshihisa Shitara et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Drug safety evaluation of rotigotine
- (2012) Fabienne Stephanie Sprenger et al. Expert Opinion On Drug Safety
- Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease
- (2012) Hirokazu Doi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
- (2012) Karen Barnett et al. LANCET
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- Amantadine: The journey from fighting flu to treating Parkinson disease
- (2012) G. Hubsher et al. NEUROLOGY
- Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease
- (2012) Jyhgong Gabriel Hou et al. PARKINSONISM & RELATED DISORDERS
- Die PRISCUS-Liste im klinischen Test
- (2012) S. Siebert et al. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
- Evaluation of drug–drug interaction screening software combined with pharmacist intervention
- (2012) Cristiano S. Moura et al. International Journal of Clinical Pharmacy
- A Prospective Study of Bowel Movement Frequency and Risk of Parkinson's Disease
- (2011) X. Gao et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients
- (2011) Hilary Hamilton et al. ARCHIVES OF INTERNAL MEDICINE
- Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
- (2011) Willi Cawello et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
- (2011) Anthony H.V. Schapira CNS DRUGS
- The Monoamine Oxidase Type B Inhibitor Rasagiline in the Treatment of Parkinson Disease: Is Tyramine a Challenge?
- (2011) Jack J. Chen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
- (2011) Peter Jenner et al. MOVEMENT DISORDERS
- Demenz und Depression determinieren Pflegebedürftigkeit bei M. Parkinson
- (2011) O. Riedel et al. NERVENARZT
- Prevalence of orthostatic hypotension in Parkinson’s disease: A systematic review and meta-analysis
- (2011) Daan C. Velseboer et al. PARKINSONISM & RELATED DISORDERS
- Depression and care-dependency in Parkinson’s disease: Results from a nationwide study of 1449 outpatients
- (2011) O. Riedel et al. PARKINSONISM & RELATED DISORDERS
- Gastroparesis and Parkinson’s disease: A systematic review
- (2011) Zaid S. Heetun et al. PARKINSONISM & RELATED DISORDERS
- The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease
- (2011) M. Mostafa Mokhles et al. PHARMACOLOGICAL RESEARCH
- COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
- (2011) Angelo Antonini Neuropsychiatric Disease and Treatment
- Parkinson’s disease and the frequent reasons for emergency admission
- (2011) Ozlem Guneysel Neuropsychiatric Disease and Treatment
- MAO-inhibitors in Parkinson's Disease
- (2011) Peter Riederer et al. Experimental Neurobiology
- Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
- (2010) P. A. Kempster et al. BRAIN
- Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinsonʼs Disease
- (2010) Jaime Kulisevsky et al. DRUG SAFETY
- Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinsonʼs Disease
- (2010) Lindy D. Wood DRUGS & AGING
- Liver toxicity possibly related with ropinirole use in the treatment of restless legs syndrome
- (2010) F. Navacerrada et al. EUROPEAN JOURNAL OF NEUROLOGY
- Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists
- (2010) Karina L. Bienfait et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Evidence-based initiation of dopaminergic therapy in Parkinson's disease
- (2010) Janis M. Miyasaki JOURNAL OF NEUROLOGY
- Parkinson's disease symptoms: The patient's perspective
- (2010) Marios Politis et al. MOVEMENT DISORDERS
- Levodopa: the story so far
- (2010) Alison Abbott NATURE
- Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson’s disease
- (2010) Hiroshi Nagayama et al. PARKINSONISM & RELATED DISORDERS
- Determinants of health-related quality of life in Parkinson’s disease: A systematic review
- (2010) Sze-Ee Soh et al. PARKINSONISM & RELATED DISORDERS
- Levodopa: Past, Present, and Future
- (2009) Robert A. Hauser EUROPEAN NEUROLOGY
- Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
- (2009) U. Ehrt et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries
- (2009) B. Santos-Eggimann et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management
- (2009) Roberto Ceravolo et al. PARKINSONISM & RELATED DISORDERS
- Transdermal Rotigotine: A Clinically Innovative Dopamine-Receptor Agonist for the Management of Parkinson's Disease
- (2009) Jack J Chen et al. PHARMACOTHERAPY
- The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons
- (2008) James L. Rudolph ARCHIVES OF INTERNAL MEDICINE
- Clinical risk-benefit assessment of dopamine agonists
- (2008) J. C. Möller et al. EUROPEAN JOURNAL OF NEUROLOGY
- Real-Life Evaluations of Compliance with Mandatory Drug Safety Monitoring Exemplified with Tolcapone in Parkinson’s Disease
- (2008) Marcus M. Unger et al. EUROPEAN NEUROLOGY
- Predictors and course of health-related quality of life in Parkinson's disease
- (2008) Elin Bjelland Forsaa et al. MOVEMENT DISORDERS
- Apomorphine for the acute treatment of “off” episodes in Parkinson's disease
- (2007) Mark Stacy et al. PARKINSONISM & RELATED DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started